| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/22/2009 | CA2188816C Composition containing .alpha.-fodrin or .alpha.- fodrin fragment protein |
| 09/17/2009 | WO2009114878A2 Methods and compositions for genetic and retinal disease |
| 09/17/2009 | WO2009114828A1 Compositions and methods relating to gastrointestinal allergic conditions |
| 09/17/2009 | WO2009114826A2 Treatment systems and methods for renal-related diseases |
| 09/17/2009 | WO2009114816A2 Therapeutic cancer antigens |
| 09/17/2009 | WO2009114703A2 Combination therapy for the treatment of cancer |
| 09/17/2009 | WO2009114585A1 Anti-tyrp1 antibodies |
| 09/17/2009 | WO2009114547A2 Enhanced dendritic cells for cancer immunotherapy |
| 09/17/2009 | WO2009114534A1 Multi-gene classifiers and prognostic indicators for cancers |
| 09/17/2009 | WO2009114485A2 Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use |
| 09/17/2009 | WO2009114335A2 Pd-1 binding proteins |
| 09/17/2009 | WO2009114207A2 Replication-defective flavivirus vaccines and vaccine vectors |
| 09/17/2009 | WO2009114202A2 Vaccine and immunization method using plasmodium antigen 2 |
| 09/17/2009 | WO2009114188A1 Newcastle disease virus monoclonal antibodies |
| 09/17/2009 | WO2009114110A1 Engineered fusion molecules immunotherapy in cancer and inflammatory diseases |
| 09/17/2009 | WO2009114083A2 Determinants of antiviral response |
| 09/17/2009 | WO2009114040A2 Anti-il-12/23p40 antibodies, epitopes, formulations, compositions, methods and uses |
| 09/17/2009 | WO2009113810A2 Pharmaceutical composition, use thereof, and method for the treatment or prevention of allergic and autoimmune diseases |
| 09/17/2009 | WO2009113665A1 Method of producing drug for swine atrophic rhinitis |
| 09/17/2009 | WO2009113664A1 Recombinant dermonecrotic toxoid-containing drug for swine atrophic rhinitis |
| 09/17/2009 | WO2009113649A1 Antibody having an immune-enhancement function |
| 09/17/2009 | WO2009113637A1 Novel thiazole derivative, matrix having thiazole derivative immobilized thereon, method for production of the thiazole derivative, and method for production of the matrix |
| 09/17/2009 | WO2009113542A1 HBs-PEPTIDE CONJUGATE |
| 09/17/2009 | WO2009113295A1 C2orf18 as target gene for cancer therapy and diagnosis |
| 09/17/2009 | WO2009113083A1 A monoclonal antibody and a method thereof |
| 09/17/2009 | WO2009113065A1 Immuno-modulating compositions for the treatment of immune-mediated disorders |
| 09/17/2009 | WO2009112792A1 Targeted identification of immunogenic peptides |
| 09/17/2009 | WO2009112603A1 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof |
| 09/17/2009 | WO2009112502A1 Agent for treating disease |
| 09/17/2009 | WO2009111892A1 Microrna mediated oncolytic targeting |
| 09/17/2009 | WO2009111889A1 Lymphocyte control of obesity and insulin resistance |
| 09/17/2009 | WO2009111865A1 Reagents and methods for detecting influenza virus proteins |
| 09/17/2009 | WO2009111849A1 Method for stabilized vaccine production |
| 09/17/2009 | WO2009087173A3 Antibody designated barb3, barb3 related antibodies, and methods of making and using same |
| 09/17/2009 | WO2009082664A8 Genetically modified attenuated vesicular stomatitis virus, compositions and methods of use thereof |
| 09/17/2009 | WO2009081440A3 Allergens and allergoids from bee venom |
| 09/17/2009 | WO2009055783A3 Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
| 09/17/2009 | WO2008101179A8 Use of sucrose to suppress mannitol-induced protein aggregation |
| 09/17/2009 | WO2008084106A9 Anti-kir antibodies, formulations, and uses thereof |
| 09/17/2009 | WO2008021295A3 Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of hiv-1 |
| 09/17/2009 | US20090234103 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 09/17/2009 | US20090233992 Hepatitis c virus vaccine |
| 09/17/2009 | US20090233871 Complexed polypeptide and adjuvant for improved vaccines |
| 09/17/2009 | US20090233857 Dna vaccine compositions and methods of use |
| 09/17/2009 | US20090233855 Compounds and methods for modulating activation of nf-kb |
| 09/17/2009 | US20090233847 Coupling Proteins to a Modified Polysaccharide |
| 09/17/2009 | US20090233803 Chromogenic in situ hybridization methods, kits, and compositions |
| 09/17/2009 | US20090232910 Biomarkers and therapeutics targets for cognitive decline |
| 09/17/2009 | US20090232901 Polymeric microspheres |
| 09/17/2009 | US20090232891 Cell Transport Compositions and Uses Thereof |
| 09/17/2009 | US20090232868 Nitric Oxide Releasing Polymer Composition |
| 09/17/2009 | US20090232865 End-Capped Poly(Ester Amide) Copolymers |
| 09/17/2009 | US20090232854 Uses of bispecific antibody coated dendritic cells pulsed with antigens and gm-csf in immune regulation |
| 09/17/2009 | US20090232852 Use of outer membrane protein a (ompa) in treatment/prevention/diagnosis of infections caused by klebsiella pneumoniae and other gram-negative bacteria |
| 09/17/2009 | US20090232851 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative |
| 09/17/2009 | US20090232850 Therapeutic treatments using botulinum neurotoxin |
| 09/17/2009 | US20090232849 Methods and compositions for the treatment of cancer |
| 09/17/2009 | US20090232848 Methods for cultivating lawsonia intracellularis |
| 09/17/2009 | US20090232847 Immunogenic compositions |
| 09/17/2009 | US20090232846 Pestivirus mutant for use in a vaccine |
| 09/17/2009 | US20090232845 Anti-peptide monoclonal antibodies (MAb's) specific for Exotic Newcastle Disease (END) are used for rapid diagnostic identification between poultry infected with vaccine strains of NDV (LaSota/B1) and END virus (ENDV) |
| 09/17/2009 | US20090232844 Immunopotentiating compounds |
| 09/17/2009 | US20090232843 Identifying and predicting influenza variants and uses thereof |
| 09/17/2009 | US20090232842 HPV Vaccine Comprising Peptides From Host Cell Proteins |
| 09/17/2009 | US20090232841 Optimzed vaccines to provide protection against ebola and other viruses |
| 09/17/2009 | US20090232840 Vaccines against escherichia coli o157 infection |
| 09/17/2009 | US20090232839 Glycoprotein-100 peptide for use as tool in treatment and diagnosis of cancer and viral infection |
| 09/17/2009 | US20090232838 Ligands of melanocortin receptors |
| 09/17/2009 | US20090232837 Anti tumoral immunogenic peptides and vaccine thereof |
| 09/17/2009 | US20090232836 Vaccine Compositions for Inducing Immune Responses Against Components of Drusen |
| 09/17/2009 | US20090232835 Composition for delivery of hematopoietic growth factor |
| 09/17/2009 | US20090232834 Methods and Agents to Treat Autoimmune Diseases |
| 09/17/2009 | US20090232833 Polyalkylene oxides having hindered ester-based biodegradable linkers |
| 09/17/2009 | US20090232832 Polyclonal antiserum against a universal tumor antigen |
| 09/17/2009 | US20090232831 Methods and compositions for the treatment or prevention of human immunodeficiency virus infection |
| 09/17/2009 | US20090232830 Modified HIV-1 Envelope Proteins |
| 09/17/2009 | US20090232829 Methods and compositions for treating inflammatory conditions |
| 09/17/2009 | US20090232828 Methods of Using IGFIR and ABL Kinase Modulators |
| 09/17/2009 | US20090232827 Compositions and methods of use of compounds to increase cancer patient survival time |
| 09/17/2009 | US20090232826 Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2 |
| 09/17/2009 | US20090232825 Methods and Compositions For Modulating Immunity |
| 09/17/2009 | US20090232824 Bivm (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof |
| 09/17/2009 | US20090232823 Anti-tyrp1 antibodies |
| 09/17/2009 | US20090232822 Lung disease targets and uses thereof |
| 09/17/2009 | US20090232821 Use Of A Growth-Stimulating Protein |
| 09/17/2009 | US20090232820 Neisseria meningitidis antigens and compositions |
| 09/17/2009 | US20090232819 Method using snail transcriptional repressor |
| 09/17/2009 | US20090232818 Prognosis and Treatment of Breast Cancer |
| 09/17/2009 | US20090232817 Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof |
| 09/17/2009 | US20090232816 Il-1 eta dna and polypeptides |
| 09/17/2009 | US20090232815 Monoclonal antibody or antibody fragment which binds a pleiotrophin-binding fragment of human Anaplastic Lymphoma Kinase (ALK) and inhibits a pleiotrophin-mediated activity; prevents pleiotrophin-mediated neoplastic or mitogenic activity |
| 09/17/2009 | US20090232814 Cancer biomarker genes and gene products and methods for using the same |
| 09/17/2009 | US20090232813 Four-Jointed Box (FJX1) In Cancer Diagnosis and Treatment |
| 09/17/2009 | US20090232812 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 09/17/2009 | US20090232811 Bivalent, bispecific antibodies |
| 09/17/2009 | US20090232810 Immunoconjugates targeting cd138 and uses thereof |
| 09/17/2009 | US20090232809 Type 2 cytokine receptor and nucleic acids encoding same |
| 09/17/2009 | US20090232808 Molecules and chimeric molecules thereof |
| 09/17/2009 | US20090232807 Glp-1 analog fusion protein formulations |
| 09/17/2009 | US20090232806 Anti-CD70 Antibody And Its Use For The Treatment And Prevention Of Cancer And Immune Disorders |